The roles od Elongation Factor 1 and Matrix in HIV-1 core disassembly
延伸因子 1 和基质在 HIV-1 核心分解中的作用
基本信息
- 批准号:7339913
- 负责人:
- 金额:$ 4.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-10 至 2009-07-09
- 项目状态:已结题
- 来源:
- 关键词:Activated LymphocyteAddressAdverse effectsAffectAmino AcidsAnti-Retroviral AgentsAntibodiesAreaAttenuatedBiologicalBiological AssayBiologyCapsidCell LineCellsCytosolFaceFibrinogenGelGenomeGoalsHIVHIV-1Highly Active Antiretroviral TherapyInfectionLaboratoriesLeadMass Spectrum AnalysisMutateOnset of illnessPatientsPeptide Elongation Factor 1PlayProcessProteinsRNA-Directed DNA PolymeraseRateRecombinantsReporterResearchResearch PersonnelRoleStructureT-LymphocyteTechnologyTestingTransportationViralViral GenomeViral Load resultViral Matrix ProteinsVirushuman EEF1A1 proteininterestmatrix protein, Human immunodeficiency virus type 1mutantnovelresearch studysizestable cell line
项目摘要
DESCRIPTION (provided by applicant): HIV-1/AIDS continues to be a global problem as no cure exists. While highly active anti-retroviral therapy is available to reduce viral loads in patients and delay the onset of disease, these treatments are costly, have numerous side effects and face a constantly mutating virus. Recently, some researchers have focused on the role cellular factors play on specific steps of HIV-1 replication in order to develop new targets for anti- retroviral therapy. One such new area of study focuses on the misunderstood process of HIV-1 core uncoating. Uncoating is defined specifically as the disassembly of the viral conical core and subsequent release of the viral genome. The Aiken laboratory has established that HIV-1 core disassembly is a highly sensitive process susceptible to small alterations in capsid stability. These alterations in core stability did not disrupt the conical structure but impaired reverse transcriptase activity and attenuated HIV-1 replication. The objective of this research is to identify the viral and cellular factors that play a role in core disassembly in order to achieve a better understanding of HIV-1 biology. This objective will be achieved by addressing three specific aims: 1. To identify a cellular factor that plays a role in HIV-1 core disassembly. 2. To determine the biological significance of this factor on HIV-1 infection. 3. To determine the role of core associated viral MA in HIV-1 uncoating and identify specific residues in MA responsible for uncoating. Completion of these three specific aims should open up a new area of research into the early post entry steps of HIV-1 replication with the possibility for identifying novel targets of anti-retroviral therapy.
描述(由申请人提供):HIV-1/艾滋病仍然是一个全球性的问题,因为没有治愈的存在。虽然有高度活性的抗逆转录病毒疗法可用于减少患者体内的病毒载量并延迟疾病的发作,但这些治疗费用昂贵,有许多副作用,并面临不断变异的病毒。最近,一些研究人员关注细胞因子在HIV-1复制的特定步骤中的作用,以开发抗逆转录病毒治疗的新靶点。其中一个新的研究领域集中在被误解的HIV-1核心脱壳过程。脱壳被具体定义为病毒锥形核心的分解和随后病毒基因组的释放。Aiken实验室已经确定HIV-1核心拆解是一个高度敏感的过程,对衣壳稳定性的微小改变敏感。核心稳定性的这些改变并没有破坏锥形结构,但损害了逆转录酶活性并减弱了HIV-1的复制。本研究的目的是确定在核心拆卸中发挥作用的病毒和细胞因子,以更好地了解HIV-1生物学。这一目标将通过实现三个具体目标来实现:1.鉴定在HIV-1核心分解中起作用的细胞因子。2.目的探讨该因子在HIV-1感染中的生物学意义。3.确定核心相关病毒MA在HIV-1脱壳中的作用,并确定MA中负责脱壳的特定残基。这三个具体目标的完成应开辟一个新的研究领域,进入艾滋病毒-1复制的早期后步骤,有可能确定新的抗逆转录病毒治疗的目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Richard Hout其他文献
David Richard Hout的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Richard Hout', 18)}}的其他基金
The roles od Elongation Factor 1 and Matrix in HIV-1 core disassembly
延伸因子 1 和基质在 HIV-1 核心分解中的作用
- 批准号:
7529005 - 财政年份:2007
- 资助金额:
$ 4.68万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 4.68万 - 项目类别:
Research Grant